🟢 GT Biopharma is trading 13.82% up today amid speculative momentum and no confirmed catalyst

GT Biopharma is trading 13.82% up at $9.80, extending speculative momentum after rising 39.32% to $8.61 on September 11; no new September 14 company announcement or clearly confirmed catalyst was identified.

• The latest listed release concerned the September 11 TriKE® platform presentation.
• Approximately 544,000 shares traded versus a roughly 105,000-share average, suggesting continued speculative momentum.
• The broader market is lower, so macro sentiment does not explain the gain.